NORTHERN TRUST CORP - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 55 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q3 2023$47,097
-63.9%
362,2830.0%0.00%
Q2 2023$130,422
-23.7%
362,283
-0.3%
0.00%
Q1 2023$170,824
-1.4%
363,456
+4.9%
0.00%
Q4 2022$173,292
-21.2%
346,5840.0%0.00%
Q3 2022$220,000
-12.4%
346,584
+8.9%
0.00%
Q2 2022$251,000
-2.0%
318,3170.0%0.00%
Q1 2022$256,000
-23.4%
318,317
-3.8%
0.00%
Q4 2021$334,000
-22.3%
330,8220.0%0.00%
Q3 2021$430,000
+72.0%
330,822
+2.7%
0.00%
Q2 2021$250,000
-26.0%
321,9830.0%0.00%
Q1 2021$338,000
-9.6%
321,983
+16.9%
0.00%
Q4 2020$374,000
+74.0%
275,355
-1.8%
0.00%
Q3 2020$215,000
-1.4%
280,480
-0.4%
0.00%
Q2 2020$218,000
+21.1%
281,726
-6.1%
0.00%
Q1 2020$180,000
-66.8%
300,048
+25.9%
0.00%
Q4 2019$542,000
+263.8%
238,417
+0.7%
0.00%
Q3 2019$149,000
-26.6%
236,8180.0%0.00%
Q2 2019$203,000
+2.5%
236,818
+30.1%
0.00%
Q1 2019$198,000
+81.7%
181,966
-0.4%
0.00%
Q4 2018$109,000
-22.7%
182,641
+18.9%
0.00%
Q3 2018$141,000
+110.4%
153,5690.0%0.00%
Q2 2018$67,000
-86.7%
153,569
-76.6%
0.00%
Q1 2018$502,000
-32.3%
656,322
+2.8%
0.00%
Q4 2017$741,000
-13.2%
638,557
-1.2%
0.00%
Q3 2017$854,000
-12.9%
646,456
+11.6%
0.00%
Q2 2017$980,000579,3130.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Boxer Capital, LLC 10,188,312$11,105,0001.28%
Stonepine Capital Management, LLC 2,008,006$2,189,0001.26%
CVI Holdings, LLC 909,625$991,0000.94%
Vivo Capital, LLC 6,818,181$7,432,0000.74%
Broadfin Capital, LLC 2,727,272$2,973,0000.61%
Telemetry Investments, L.L.C. 650,000$708,0000.36%
Granite Point Capital Management, L.P. 1,706,134$1,860,0000.18%
J. Goldman & Co LP 1,045,000$1,139,0000.06%
Tibra Equities Europe Ltd 241,966$264,0000.03%
IPG Investment Advisors LLC 42,500$46,325,0000.02%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders